The Enterprise Value as of December 2024 (TTM) for Olema Pharmaceuticals, Inc. (OLMA) is 326.79M

According to Olema Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 326.79M. This represents a change of -48.49% compared to the average of 634.44M of the last 4 quarters.

Olema Pharmaceuticals, Inc. (OLMA) Historical Enterprise Value (quarterly & annually)

How has OLMA Enterprise Value performed in the past?

The mean historical Enterprise Value of Olema Pharmaceuticals, Inc. over the last ten years is 823.14M. The current 326.79M Enterprise Value has changed 3.87% with respect to the historical average. Over the past ten years (40 quarters), OLMA's Enterprise Value was at its highest in in the September 2020 quarter at 1.71B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Olema Pharmaceuticals, Inc. (OLMA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Olema Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Olema Pharmaceuticals, Inc. (OLMA) Average Enterprise Value

How has OLMA Enterprise Value performed in the past?

The current Enterprise Value of Olema Pharmaceuticals, Inc. (OLMA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Olema Pharmaceuticals, Inc. (OLMA) Enterprise Value vs. Peers

How is OLMA’s Enterprise Value compared to its peers?

Olema Pharmaceuticals, Inc.’s Enterprise Value is less than Sana Biotechnology, Inc. (360.93M), less than Cullinan Oncology, Inc. (604.04M), greater than aTyr Pharma, Inc. (138.44M), greater than Zentalis Pharmaceuticals, Inc. (230.39M), greater than Molecular Partners AG (107.67M), less than Mineralys Therapeutics, Inc. (527.57M), greater than AN2 Therapeutics, Inc. (7.88M), less than Pharvaris N.V. (659.40M), greater than PepGen Inc. (102.90M), less than Gracell Biotechnologies Inc. (5.66B), greater than Theseus Pharmaceuticals, Inc. (138.26M), less than Monte Rosa Therapeutics, Inc. (352.48M), greater than Design Therapeutics, Inc. (324.94M), less than Erasca, Inc. (710.69M), less than Disc Medicine, Inc. (1.75B), greater than Larimar Therapeutics, Inc. (214.00M), greater than Fennec Pharmaceuticals Inc. (159.78M), greater than Orchestra BioMed Holdings, Inc. (158.32M), greater than Nuvectis Pharma, Inc. (72.67M), less than Centessa Pharmaceuticals plc (1.88B),

Build a custom stock screener for Olema Pharmaceuticals, Inc. (OLMA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Olema Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Olema Pharmaceuticals, Inc. (OLMA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Olema Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.